Source: Annual Congress 2001 - Cellular immunopathology of rhinitis and asthma
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
G. Woltmann, C. A. McNulty, D. Salvadore, J. A. Cook, I. D. Pavord, D. Robinson, A. J. Wardlaw (Leicester, London, United Kingdom). P-selectin expression in chronic allergic airway inflammation. Eur Respir J 2001; 16: Suppl. 31, 1829

Member's Comments

No comment yet.

Related content which might interest you: CCL6 produced by eosinophils drives allergic airway inflammation in mice Source: International Congress 2019 – Modelling and monitoring of airway diseases Year: 2019 High-level expression of PD-L1 by DC suppresses airway inflammation in OVA-induced allergic asthma Source: Annual Congress 2010 - Animal models of asthma and lung inflammation Year: 2010 ILC2s in allergic airway inflammation Source: International Congress 2014 – Highlights from the Lung Science Conference 2014 Year: 2014 The effect of Der f-induced airway inflammation on airway inflammation in a murine model of allergic asthma Source: Eur Respir J 2004; 24: Suppl. 48, 348s Year: 2004 Effect of previous physical conditioning on pulmonary inflammation and allergic immune response in a chronic allergic airway inflammation in mice Source: Eur Respir J 2007; 30: Suppl. 51, 370s Year: 2007 Estrogen prevents airway inflammation and hyperresponsiveness in a murine model of acute allergic asthma Source: Eur Respir J 2007; 30: Suppl. 51, 360s Year: 2007 Osteopontin blockade prevents fibrosis in a murine chronic model of allergic airway disease Source: Eur Respir J 2007; 30: Suppl. 51, 60s Year: 2007 Imiquimod attenuate airway inflammation and decrease the expression of TARC in allergic asthmatic mice Source: Eur Respir J 2006; 28: Suppl. 50, 224s Year: 2006 The role of CCR5 in allergen-induced airway hyperresponsiveness and airway inflammation Source: Annual Congress 2009 - Animal models of airways inflammation Year: 2009 Effects of OVA-induced allergic airway inflammation and remodeling in mice in three distinct asthma models Source: Annual Congress 2010 - Animal models of asthma and lung inflammation Year: 2010 MMP-9 deficiency reduces airway inflammation and hyperresponsiveness in a mouse model of asthma Source: Eur Respir J 2001; 18: Suppl. 33, 20s Year: 2001 A potential role of P2X7R in allergic airway inflammation Source: Annual Congress 2010 - Asthma: basic science and clinical studies Year: 2010 IL-33 blockade impacts mediators of persistence and exacerbation of chronic airway inflammation. Source: International Congress 2018 – Novel drug targets for asthma and COPD Year: 2018 Osteopontin exacerbates airway hyperresponsiveness and lung remodeling in chronic asthma Source: Annual Congress 2008 - Basic science in asthma and COPD Year: 2008 The inflammation and the airway hyperresponsiveness in allergic asthma is inhibited by IL-10 dependent mechanism Source: Annual Congress 2007 - Mouse models of allergic airway inflammation Year: 2007 Role of IL-33 signaling in pollutant-induced allergic airway inflammation Source: International Congress 2018 – Translational models of the immunopathology that underlies airway obstructive diseases Year: 2018 Comparison of the inflammatory response between two chronic models of allergic lung inflammation Source: Eur Respir J 2007; 30: Suppl. 51, 368s Year: 2007 Cytokine-status in allergic airway inflammation provoked by latex Source: Eur Respir J 2002; 20: Suppl. 38, 511s Year: 2002 Autoimmunity  in airway inflammation and asthma Source: International Congress 2017 – GR3 Scientific Grand Round: Autoimmunity in chronic lung disease Year: 2017 The airway inflammatory response in allergic mice is downregulated by budesonide Source: Eur Respir J 2001; 18: Suppl. 33, 265s Year: 2001